How Exercise Helps Reduce Inflammation in MS Patients

Credibility

Interest

Key Takeaway

Regular exercise can help reduce inflammation in people with MS, regardless of the type of exercise they do.

What They Found

The study looked at how two types of exercise, high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), affected certain chemicals in the body of people with MS. They found that both types of exercise lowered most of these chemicals over time, which is a good thing because it means less inflammation. For example, think of inflammation like a fire in your body; exercise helps put that fire out. Interestingly, people who started with higher levels of inflammation showed different changes in these chemicals compared to those with lower levels. This suggests that how inflamed your body is can change how your body responds to exercise.

Who Should Care and Why

MS patients should care about these findings because they show that exercise can play a big role in reducing inflammation, which might help with symptoms. Just like watering plants helps them grow better, regular movement can help your body feel better. Caregivers can also benefit by encouraging those they care for to stay active, knowing it can lead to positive changes. Healthcare providers can use this information to promote exercise as a part of MS treatment plans. Overall, everyone involved in MS care can see that staying active is important for managing health.

Important Considerations

One limitation of the study is that it only looked at short-term effects, so we don't know how long the benefits of exercise might last. Also, the study participants were a specific group, which means results may not apply to everyone with MS. Lastly, individual responses to exercise can vary, so what works for one person may not work for another.

Categories:

Clinical Trials Specific Symptoms MS Progression

Article Topics:

Multiple sclerosisNLRendurance traininginflammationkynureninetryptophan

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like International journal of tryptophan research : IJTR often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News